Related Experiment Videos
Characterizing anxiety in melanoma patients
Sharif B Missiha1, Nowell Solish, Lynn From
1Sunnybrook and Women's Health Sciences Centre, Toronto, Ontario, Canada.
Journal of Cutaneous Medicine and Surgery
|June 1, 2005
Summary
Over half of melanoma patients experience high anxiety, impacting treatment. Identifying risk factors like female gender and older age helps predict and manage this distress effectively.
Area of Science:
- Oncology
- Psychology
- Dermatology
Background:
- Melanoma diagnosis frequently causes significant anxiety in over 50% of patients.
- This psychological distress can delay crucial diagnosis and treatment initiation.
- Understanding anxiety triggers is vital for patient care in melanoma.
Purpose of the Study:
- Identify melanoma patients at high risk for anxiety.
- Characterize factors contributing to anxiety and patient coping mechanisms.
- Investigate interventions to alleviate anxiety in melanoma patients.
Main Methods:
- Surveys administered to 94 melanoma patients at a specialized clinic.
- Assessment of self-reported anxiety, contributing factors, and coping strategies.
- Exploration of potential anxiety-reducing services.
Main Results:
- Female gender and increasing age are significant risk factors for anxiety (p=0.002, p=0.004).
- Prognosis, fear of death, and physician attitude are key anxiety contributors.
- Family support, doctor assistance, and self-distraction are primary coping strategies.
- Information pamphlets are identified as a potentially useful intervention.
Conclusions:
- Melanoma patients with high anxiety can be identified through specific risk factors.
- Proactive management strategies can effectively minimize patient distress.
- Targeted interventions can improve the psychological well-being of melanoma patients.